Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 55, 30-35
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6RNA, 2012
- A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsyEpilepsia, 2011
- Critical association of ncRNA with intronsNucleic Acids Research, 2010
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- The clinical impact of pharmacogenetics on the treatment of epilepsyEpilepsia, 2009
- Intrinsic Severity as a Determinant of Antiepileptic Drug RefractorinessEpilepsy Currents, 2008
- Association between SCN1A polymorphism and carbamazepine‐resistant epilepsyBritish Journal of Clinical Pharmacology, 2008
- A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsyEpilepsia, 2008
- A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dosePharmacogenetics and Genomics, 2006
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989